In addition to NO donors, AT2R blockers and statins or regular physical exercise also provide neuroprotective effects via eNOS/NO/cGMP-dependent path-ways as shown by studies using acute and chronic experimental stroke animal models [218]. The gene discussed is NOS3; the disease is stroke disorder.